Journal of Precision Biosciences

Anton Yuryev ^A, John Catanzaro ^B, Md Shamsuddin Sultan Khan ^C

John Catanzaro ^A, Andrew Dickens ^B
 

Regenerative physicians and practitioners are true revolutionaries for the advancement of medicine and healthcare.

Anton Yuryev ^A, John Catanzaro ^B, Md Shamsuddin Sultan Khan ^C

Anton Yuryev ^A, John Catanzaro ^B, Md Shamsuddin Sultan Khan ^C

Anton Yuryev ^A, John Catanzaro ^B, Md Shamsuddin Sultan Khan ^C

John A Catanazaro^1*, Md Shamsuddin Sultan Khan ¹, Mohamed Khadeer Ahmded Basheer ², Anton Yuryev ¹, Andrew Dickens ¹

Neoantigen cancer vaccine is highly effective to treat the various types of cancer which is conducted in 2001 to 2014 at Health and Wellness Institute Integrative Cancer Treatment under the direction of Dr. Catanzaro and his team of physicians. 

John A. Catanzaro

Short peptide self-assembly can be potent molecules, particularly in
the precision / personalized medicine arena. 

Md Shamsuddin Sultan Khan ^1*, Fouad Saleh Resq Al-Suede ², Mohamed Khadeer Ahamed Basheer ² , Amin Malik Shah Abdul Majid ³

Genetic profiling revolutionizing precision cancer therapies, offering personalized treatments and reshaping oncology's development for enhanced patient outcomes.

Md. Kamrul Hasan Chowdhury ¹, Md Shamsuddin Sultan Khan ²

Individualized immunotherapy in precision medicine revolutionizes treatments based on unique immunological profiles, promising targeted therapies across medical disciplines.

Wei Zhang ^{1, 2}, Shamsuddin Sultan Khan ^1*, John Catanzaro ¹

Cancer's complexity necessitates personalized treatment approaches for optimal outcomes. Individualized therapeutic design, tailoring treatments based on patient-specific factors, offers a promising strategy.

Anton Yuryev ^A, John Catanzaro ^B, Md Shamsuddin Sultan Khan ^C

Neo7logix precision profiling brief data for progressive CNS inflammation and autoimmune disease.

John Catanzaro ^A, Andrew Dickens ^B
 

Regenerative physicians and practitioners are true revolutionaries for the advancement of medicine and healthcare.

Anton Yuryev ^A, John Catanzaro ^B, Md Shamsuddin Sultan Khan ^C

Brief data for sample Syrinx, CSF Leak, Autoimmune Reactive Disease CNS / CNS Autoantigen Inflammation  

Anton Yuryev ^A, John Catanzaro ^B, Md Shamsuddin Sultan Khan ^C

A precision mapping, ranking and selection profile is generated to derive a precision-based personalized Immuno-molecular Augmentation therapeutic application that activates the immune system defenses and regulatory mechanisms to intelligently fight the cancer and / or disease process. 

Anton Yuryev ^A, John Catanzaro ^B, Md Shamsuddin Sultan Khan ^C

NGS RNAseq tumor transcriptomics profile was generated by Genoanalytica, Moscow Russia. RPKM values for every gene measured in tumor sample were normalized on transcriptomics profile from three samples of normal gallbladder from publicly available GSE132223 data from National Cancer Institute (NCBI): M3-741_tpm, M3-760_tpm, M3-817_tpm

John A Catanazaro^1*, Md Shamsuddin Sultan Khan ¹, Mohamed Khadeer Ahmded Basheer ², Anton Yuryev ¹, Andrew Dickens ¹

Neoantigen cancer vaccine is highly effective to treat the various types of cancer which is conducted in 2001 to 2014 at Health and Wellness Institute Integrative Cancer Treatment under the direction of Dr. Catanzaro and his team of physicians. 

John A. Catanzaro

Short peptide self-assembly can be potent molecules, particularly in
the precision / personalized medicine arena. 

Md Shamsuddin Sultan Khan ^1*, Fouad Saleh Resq Al-Suede ², Mohamed Khadeer Ahamed Basheer ² , Amin Malik Shah Abdul Majid ³

Genetic profiling revolutionizing precision cancer therapies, offering personalized treatments and reshaping oncology's development for enhanced patient outcomes.

Md. Kamrul Hasan Chowdhury ¹, Md Shamsuddin Sultan Khan ²

Individualized immunotherapy in precision medicine revolutionizes treatments based on unique immunological profiles, promising targeted therapies across medical disciplines.

Wei Zhang ^{1, 2}, Shamsuddin Sultan Khan ^1*, John Catanzaro ¹

Cancer's complexity necessitates personalized treatment approaches for optimal outcomes. Individualized therapeutic design, tailoring treatments based on patient-specific factors, offers a promising strategy.